NGNE Earnings Neurogene Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–31 of 31
| Q2 2026 | 2026-06-30 | -2.92 | 2026-08-11 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.39 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -4.24 | 2026-03-24 | 10-K |
| Q3 2025 | 2025-09-30 | -3.11 | 2025-11-13 | 10-Q |
| Q2 2026 | 2025-06-30 | -2.12 | 2026-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.08 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -4.28 | 2026-03-24 | 10-K |
| Q3 2025 | 2024-09-30 | -3.29 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.09 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.00 | 2025-05-09 | 10-Q |
| FY 2024 | 2023-12-31 | 2.93 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -87.66 | 2024-11-18 | 10-Q |
| Q2 2024 | 2023-06-30 | -54.94 | 2024-08-09 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.26 | 2023-05-08 | 10-Q |
| FY 2022 | 2022-12-31 | -1.04 | 2023-03-20 | 10-K |
| Q3 2023 | 2022-09-30 | -3.99 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.56 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.28 | 2023-05-08 | 10-Q |
| FY 2022 | 2021-12-31 | -1.10 | 2023-03-20 | 10-K |
| Q3 2022 | 2021-09-30 | -0.83 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.55 | 2022-08-09 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.27 | 2022-05-09 | 10-Q |
| FY 2021 | 2020-12-31 | -0.64 | 2022-03-01 | 10-K |
| Q3 2021 | 2020-09-30 | -0.41 | 2021-11-04 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.37 | 2021-08-05 | 10-Q |
| Q1 2021 | 2020-03-31 | -0.18 | 2021-05-12 | 10-Q |
| Q2 2019 | 2019-06-30 | -0.09 | 2019-08-01 | 10-Q |
| Q2 2019 | 2018-06-30 | -0.50 | 2019-08-01 | 10-Q |
| Q2 2018 | 2017-06-30 | -0.94 | 2018-08-08 | 10-Q |
| Q1 2014 | 2014-03-31 | -179.45 | 2014-05-13 | 10-Q |
| Q1 2014 | 2013-03-31 | -8.48 | 2014-05-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.